Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Rubboli

Showing results (11-20 of 201) with videos related to

Pageof 21
Sort By:
European Journal of Internal Medicine|January 24, 2019
Horizontal vs. vertical dose reduction of direct oral anticoagulants in patients with non-valvular atrial fibrillation: definition and implications for practiceAndrea Rubboli
European Journal of Internal Medicine|December 27, 2017
What is the significance, if any, of the increased incidence of stent thrombosis with dual therapy of dabigatran 110mg twice daily and clopidogrel in the RE-DUAL PCI trial?Andrea Rubboli
European Heart Journal|April 16, 2004
More about transport for primary PCI in AMIAndrea Rubboli
Current Cardiology Reviews|November 20, 2009
Efficacy and Safety of Low-Molecular-Weight Heparins As An Adjunct to Thrombolysis in Acute ST-Elevation Myocardial InfarctionAndrea Rubboli
Current Medical Research and Opinion|August 28, 2015
Adherence to and persistence with non-vitamin K-antagonist oral anticoagulants: does the number of pills per day matter?Andrea Rubboli
Giornale Italiano Di Cardiologia (2006)|November 7, 2017
[Low or reduced? Semantics of the doses of new oral anticoagulants]Andrea Rubboli
Journal of Geriatric Cardiology : JGC|July 12, 2012
The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questionsAndrea Rubboli
European Heart Journal. Cardiovascular Pharmacotherapy|October 19, 2020
Antiplatelet therapy after coronary bypass grafting: which regimen and for whom?Andrea Rubboli, Sabine Vecchio
Giornale Italiano Di Cardiologia (2006)|July 29, 2024
[Monoclonal antibodies and inclisiran: searching for the ideal patient]Andrea Rubboli, Claudio Cuccia
European Journal of Internal Medicine|April 3, 2017
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profilesGiuseppe Patti, Andrea Rubboli
Pageof 21

Showing results (11-20 of 201) with videos related to

Sort By:
Pageof 21
European Journal of Internal Medicine|January 24, 2019
Horizontal vs. vertical dose reduction of direct oral anticoagulants in patients with non-valvular atrial fibrillation: definition and implications for practiceAndrea Rubboli
European Journal of Internal Medicine|December 27, 2017
What is the significance, if any, of the increased incidence of stent thrombosis with dual therapy of dabigatran 110mg twice daily and clopidogrel in the RE-DUAL PCI trial?Andrea Rubboli
European Heart Journal|April 16, 2004
More about transport for primary PCI in AMIAndrea Rubboli
Current Cardiology Reviews|November 20, 2009
Efficacy and Safety of Low-Molecular-Weight Heparins As An Adjunct to Thrombolysis in Acute ST-Elevation Myocardial InfarctionAndrea Rubboli
Current Medical Research and Opinion|August 28, 2015
Adherence to and persistence with non-vitamin K-antagonist oral anticoagulants: does the number of pills per day matter?Andrea Rubboli
Giornale Italiano Di Cardiologia (2006)|November 7, 2017
[Low or reduced? Semantics of the doses of new oral anticoagulants]Andrea Rubboli
Journal of Geriatric Cardiology : JGC|July 12, 2012
The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questionsAndrea Rubboli
European Heart Journal. Cardiovascular Pharmacotherapy|October 19, 2020
Antiplatelet therapy after coronary bypass grafting: which regimen and for whom?Andrea Rubboli, Sabine Vecchio
Giornale Italiano Di Cardiologia (2006)|July 29, 2024
[Monoclonal antibodies and inclisiran: searching for the ideal patient]Andrea Rubboli, Claudio Cuccia
European Journal of Internal Medicine|April 3, 2017
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profilesGiuseppe Patti, Andrea Rubboli
Pageof 21